Novartis
NVS
NVS
1,134 hedge funds and large institutions have $18.6B invested in Novartis in 2021 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 416 increasing their positions, 443 reducing their positions, and 101 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,134
Holders Change
-41
Holders Change %
-3.49%
% of All Funds
19.97%
Holding in Top 10
4
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-71.43%
% of All Funds
0.07%
New
72
Increased
416
Reduced
443
Closed
101
Calls
$239M
Puts
$124M
Net Calls
+$116M
Net Calls Change
-$11.9M
Top Buyers
| 1 |
CCM
Cullen Capital Management
New York
|
$222M |
| 2 |
Goldman Sachs
New York
|
$230M |
| 3 |
Parnassus Investments
San Francisco,
California
|
$79.6M |
| 4 |
Aristotle Capital Management
Los Angeles,
California
|
$676M |
| 5 |
BlackRock
New York
|
$107M |
